Sequoia Vaccines, Inc. (SQVI)

Sequoia Vaccines Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	-	1.81	0.62
Research & Development	-	2.28	5.77
Operating Expenses	-	4.09	6.38
Operating Income	-3.12	-4.09	-6.38
Interest Expense / Income	0.1	0.1	0.07
Other Expense / Income	-0	-0	-0
Pretax Income	-4.49	-5.33	-7.08
Net Income	-3.21	-4.19	-6.45
Preferred Dividends	1.28	1.14	0.63
Net Income Common	-4.49	-5.33	-7.08
Free Cash Flow	-2.93	-3.99	-1.71
EBITDA	-4.38	-5.21	-7
Depreciation & Amortization	0.01	0.01	0.01
EBIT	-4.39	-5.23	-7.01

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).